Jason Wermers, CRTonline.org
The novel DynamX novolimus-eluting stent showed positive remodeling in implanted coronary arteries through 1 year in a small, nonrandomized study, according to a late-breaking trial presented Friday at the PCR e-Course.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details